News Releases - U.S. Dept. of Defense

DOD Awards $6.98 Million Firm-Fixed Price Contract Action to Teel Plastics, LLC to Increase Domestic Production Capacity of Swabsticks for COVID-19 Testing Swabs

The Department of Defense, in coordination with the Department of Health and Human Services, awarded a $6.98 million Firm-Fixed Price contract action to Teel Plastics, LLC, to expand US-based industrial production capacity of injection-molded and extruded swabsticks used in the production of COVID-19 testing kits.

Trump Administration Expands Collaboration With AstraZeneca to Develop and Manufacture an Investigational Monoclonal Antibody to Prevent COVID-19

The U.S. Department of Health and Human Services and Department of Defense announced an agreement with AstraZeneca for late-stage development and large-scale manufacturing of the company's COVID-19 investigational product AZD7442, a cocktail of two monoclonal antibodies, that may help treat or prevent infection with SARS-CoV-2, the coronavirus that causes COVID-19.

Pages